This year marks 15 years since aesthetic manufacturer Teoxane Laboratories has been in the facial aesthetics market.
According to the company, since its inception in 2003, the foundations of the company have been based on integrated research, development and production.
The company is now responsible for developing hyaluronic acid fillers and topical formulations. Its first injectable volumiser was the TEOSYAL Ultra Deep2, followed by TEOSYAL PureSense2 with lidocaine and the TEOSYAL PureSense Redensity2 line. In 2015, Teoxane created a new resilient hyaluronic acid, TEOSYAL RHA2 and, soon after, developed the cordless, motorised hyaluronic acid injection system TEOYSAL PEN.
As well as this, the company has developed cosmeceutical skincare products which include the Hydrogel Mask, RHA x VCIP vitamin C serum, Radiant Night Peel and Advanced Perfecting Shield SPF30.
In 2018, Teoxane has more than 200 employees, seven subsidiaries, and has sold more than nine million syringes of TEOSYAL fillers in 80 countries.